GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 47 filers reported holding GAMIDA CELL LTD in Q1 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,925,482 | -47.8% | 2,840,274 | -2.1% | 0.35% | -45.3% |
| Q2 2023 | $5,600,424 | +143.9% | 2,901,774 | +2.4% | 0.64% | +123.2% |
| Q1 2023 | $2,295,895 | +277.4% | 2,834,438 | +501.1% | 0.28% | +247.6% |
| Q4 2022 | $608,307 | +1420.8% | 471,556 | +1786.2% | 0.08% | +1540.0% |
| Q3 2022 | $40,000 | -51.8% | 25,000 | +25.0% | 0.01% | -37.5% |
| Q1 2022 | $83,000 | -53.4% | 20,000 | -71.4% | 0.01% | -52.9% |
| Q4 2021 | $178,000 | – | 70,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 3,318,207 | $26,844,000 | 2.86% |
| Stonepine Capital Management, LLC | 244,515 | $1,978,000 | 1.07% |
| Healthcare Value Capital, LLC | 50,000 | $405,000 | 0.90% |
| Rock Springs Capital Management LP | 2,100,300 | $16,991,000 | 0.37% |
| Dorsey Wright & Associates | 3,619 | $29,278,000 | 0.34% |
| FIRST MIDWEST BANK TRUST DIVISION | 302,487 | $2,447,000 | 0.34% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 107,000 | $862,000 | 0.23% |
| Guild Investment Management, Inc. | 15,000 | $121,000 | 0.13% |
| PREMIER ASSET MANAGEMENT LLC | 86,464 | $699,000 | 0.12% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 973,575 | $7,876,000 | 0.12% |